Atossa Genetics Inc Stock
Price
Target price
€1.22
€1.22
-6.140%
-0.08
-6.140%
€3.74
29.05.24 / Tradegate
WKN: A2JJ99 / Symbol: ATOS / Name: Atossa Genetics / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Atossa Genetics Inc Stock
Heavy losses for Atossa Genetics Inc today as the stock fell by -€0.080 (-6.140%).
With 7 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 3 € there is potential for a 145.5% increase which would mean more than doubling the current price of 1.22 € for Atossa Genetics Inc.
So far the community has only identified positive things for Atossa Genetics Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Atossa Genetics Inc in the next few years
Pros
?
B****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atossa Genetics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Atossa Genetics Inc | -6.140% | -9.212% | -13.333% | 42.507% | 29.862% | -53.359% | -67.361% |
| InVivo Therapeutics Holdings | -0.580% | 0.000% | 3.659% | -71.524% | -50.581% | -99.928% | -99.955% |
| Star Equity Holdings Inc. | -0.650% | -6.667% | -9.942% | -22.613% | -18.085% | -65.625% | -86.051% |
| Medmira Inc. | - | 0.000% | 6.122% | -7.143% | -20.000% | - | - |
Comments
Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for ATOS provided by MarketBeat
Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its price target raised by analysts at HC Wainwright from $4.00 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ATOS provided by MarketBeat
Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Show more
Ratings data for ATOS provided by MarketBeat